AVIR — Atea Pharmaceuticals Inc USA

HealthcareBiotechnology

[[ lastPrice | number : 2]]
[[ refundPrice | number : 2]]
[[ refundPriceP | number : 2]]%
[[ lastDate * 1000 | date:'MMM d, y @h:mm a' ]]
Currency in USD
Key statistics
Basic
Not enough data for Risks (Volatility).
Not enough data for Beta calculations.
Market capital
$670M
Employees
56
Money
Not enough data for Earnings per share statistics.
Not enough data for Book Value calculations.
Wall Street price
$13.67
PE Ratio
26.44
Dividends
Volume & Social
Short Ratio
0.69%
Daily Volume
2.51M
Volume
Below average
Social Rate
Untracked
Social Volume
Untracked
 
Latest AVIR news
[[ item.source ]] - [[ item.pubDate | date:'MMM d, y @ h:mma' ]]
[[ item.description ]]
Invest ideas
4 ideas for buy
65.70%
Wall Street Higher
Fundamental signal
The price is expected to raise
$0.31
Earnings are positive
Fundamental signal
Earnings per share are positive
0.59x
PB Ratio lower than sector
Fundamental signal
Price-to-Book lower than sector.
-76.35%
Short Ratio lower than industry
Fundamental signal
Short Interest Ratio is lower than industry.
4 ideas for sell
0.59x
PB Ratio higher than industry
Fundamental signal
Price-to-Book Ratio is higher than industry.
43.73%
Sector costly
Fundamental signal
PE Ratio is higher than sector.
32.43%
Industry costly
Fundamental signal
PE Ratio is higher than industry.
-73.83%
Below SMA 200
Technical signal
The price is below SMA for 200 days period
Invest Ideas — the best way to get insights based on both fundamental and technical data. We analyze company's performance across sector and industry and generate investing ideas for you.
Want to track signal changes?
It's easy to monitor changes in signal with our watchlist. Just add the stock to your watchlist and get daily, weekly and monthly signal changes for the asset.
Similar and Opposite stocks
Most and less correlated stocks. All correllations are calculated for 1 year period. Learn more about correlations.
Income Statement
All numbers in thousands [[fin.date | strtotimestamp | date: 'MMM d, yyyy']]
Revenue
Total Revenue [[fin.totalRevenue / 1000 | number : 0]]
Cost of Revenue [[fin.costOfRevenue / 1000 | number : 0]]
Gross Profit [[fin.grossProfit / 1000 | number : 0]]
Operating Expenses
Research Development [[fin.researchDevelopment / 1000 | number : 0]]
Selling General and Administrative [[fin.sellingGeneralAdministrative / 1000 | number : 0]]
Non Recurring [[fin.nonRecurring / 1000 | number : 0]]
Others [[fin.otherOperatingExpenses / 1000 | number : 0]]
Total Operating Expenses [[fin.totalOperatingExpenses / 1000 | number : 0]]
Operating Income or Loss [[fin.operatingIncome / 1000 | number : 0]]
Income from Continuing Operations
Total Other Income/Expenses Net [[fin.totalOtherIncomeExpenseNet / 1000 | number : 0]]
Earnings Before Interest and Taxes [[fin.ebit / 1000 | number : 0]]
Interest Expense [[fin.interestExpense / 1000 | number : 0]]
Income Before Tax [[fin.incomeBeforeTax / 1000 | number : 0]]
Income Tax Expense [[fin.incomeTaxExpense / 1000 | number : 0]]
Minority Interest [[fin.minorityInterest / 1000 | number : 0]]
Net Income From Continuing Ops [[fin.netIncomeFromContinuingOps / 1000 | number : 0]]
Non-recurring Events
Discontinued Operations [[fin.discontinuedOperations / 1000 | number : 0]]
Extraordinary Items [[fin.extraordinaryItems / 1000 | number : 0]]
Effect Of Accounting Changes [[fin.effectOfAccountingCharges / 1000 | number : 0]]
Other Items [[fin.otherItems / 1000 | number : 0]]
Net Income
Net Income [[fin.netIncome / 1000 | number : 0]]
Net Income Applicable To Common Shares [[fin.netIncomeApplicableToCommonShares / 1000 | number : 0]]
Balance Sheet
All numbers in thousands [[fin.date | strtotimestamp | date: 'MMM d, yyyy']]
Current Assets  
Cash And Cash Equivalents [[fin.cash / 1000 | number : 0]]
Short Term Investments [[fin.shortTermInvestments / 1000 | number : 0]]
Net Receivables [[fin.netReceivables/ 1000 | number : 0]]
Inventory [[fin.inventory/ 1000 | number : 0]]
Other Current Assets [[fin.otherCurrentAssets/ 1000 | number : 0]]
Total Current Assets [[fin.totalCurrentAssets / 1000 | number : 0]]
Long Term Investments [[fin.longTermInvestments / 1000 | number : 0]]
Property Plant and Equipment [[fin.propertyPlantEquipment / 1000 | number : 0]]
Goodwill [[fin.goodWill / 1000 | number : 0]]
Intangible Assets [[fin.intangibleAssets / 1000 | number : 0]]
Other Assets [[fin.otherAssets / 1000 | number : 0]]
Total Assets [[fin.totalAssets / 1000 | number : 0]]
Current Liabilities
Accounts Payable [[fin.accountsPayable / 1000 | number : 0]]
Short/Current Long Term Debt [[fin.shortLongTermDebt / 1000 | number : 0]]
Other Current Liabilities [[fin.otherCurrentLiab / 1000 | number : 0]]
Total Current Liabilities [[fin.totalCurrentLiabilities / 1000 | number : 0]]
Long Term Debt [[fin.longTermDebt / 1000 | number : 0]]
Other Liabilities [[fin.otherLiab / 1000 | number : 0]]
Deferred Long Term Liability Charges [[fin.deferredLongTermLiab / 1000 | number : 0]]
Total Liabilities [[fin.totalLiab / 1000 | number : 0]]
Stockholders' Equity
Common Stock [[fin.commonStock / 1000 | number : 0]]
Retained Earnings [[fin.retainedEarnings / 1000 | number : 0]]
Other Stockholder Equity [[fin.otherStockholderEquity / 1000 | number : 0]]
Total Stockholder Equity [[fin.totalStockholderEquity / 1000 | number : 0]]
Net Tangible Assets [[fin.netTangibleAssets / 1000 | number : 0]]
Cash Flow Statement
All numbers in thousands [[fin.date | strtotimestamp | date: 'MMM d, yyyy']]
Net Income [[fin.netIncome/ 1000 | number : 0]]
Operating Activities, Cash Flows Provided By or Used In
Depreciation [[fin.depreciation / 1000 | number : 0]]
Adjustments To Net Income [[fin.changeToNetincome / 1000 | number : 0]]
Changes In Accounts Receivables [[fin.changeToAccountReceivables / 1000 | number : 0]]
Changes In Liabilities [[fin.changeToLiabilities / 1000 | number : 0]]
Changes In Inventories [[fin.changeToInventory / 1000 | number : 0]]
Changes In Other Operating Activities [[fin.changeToOperatingActivities / 1000 | number : 0]]
Total Cash Flow From Operating Activities [[fin.totalCashFromOperatingActivities / 1000 | number : 0]]
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures [[fin.capitalExpenditures / 1000 | number : 0]]
Investments [[fin.investments / 1000 | number : 0]]
Other Cash flows from Investing Activities [[fin.otherCashflowsFromInvestingActivities / 1000 | number : 0]]
Total Cash Flows From Investing Activities [[fin.totalCashflowsFromInvestingActivities / 1000 | number : 0]]
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid [[fin.dividendsPaid / 1000 | number : 0]]
Sale Purchase of Stock [[fin.salePurchaseOfStock / 1000 | number : 0]]
Net Borrowings [[fin.netBorrowings / 1000 | number : 0]]
Other Cash Flows from Financing Activities [[fin.otherCashflowsFromFinancingActivities / 1000 | number : 0]]
Total Cash Flows From Financing Activities [[fin.totalCashFromFinancingActivities / 1000 | number : 0]]
Change In Cash and Cash Equivalents [[fin.changeInCash / 1000 | number : 0]]
 

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, a novel antiviral agent that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 that is in Phase I/IIa clinical trial for the treatment of chronic hepatitis C; and AT-889, an investigational, second-generation nucleoside pyrimidine prodrug and other compounds for the treatment of respiratory syncytial virus. It has a Roche License Agreement with F. Hoffmann-La Roche Ltd and Genentech, Inc. for development and commercialization related to AT-527 outside of the United States. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 56
Avg
0.03 -0.72 0.08 -0.98
High
1.17 -0.57 1.21 3.56
Low
-0.77 -0.87 -0.72 -3.70
Avg
75.7M 66.0M 251M 291M
High
192M 66.0M 351M 637M
Low
0 66.0M 159M 10.0M
  [[fin.date | strtotimestamp | date: 'MMM d,yyyy']]
Earnings History
Earnings Actual [[fin.epsActual | number : 2]]
Earnings Estimate [[fin.epsEstimate | number : 2]]
Difference [[fin.epsDifference | number : 2]]
Surprise [[fin.surprisePercent | number : 1]]%
  Cur Qtr ([[financials['etrend']['0q'].date | strtotimestamp | date: 'MMM yyyy']]) Next Qtr ([[financials['etrend']['+1q'].date | strtotimestamp | date: 'MMM yyyy']]) Cur Year ([[financials['etrend']['0y'].date | strtotimestamp | date: 'MMM yyyy']]) Next Year ([[financials['etrend']['+1y'].date | strtotimestamp | date: 'MMM yyyy']])
Earnings Estimate
Number of Analysts [[financials['etrend']['0q'].earningsEstimateNumberOfAnalysts | number : 0]] [[financials['etrend']['+1q'].earningsEstimateNumberOfAnalysts | number : 0]] [[financials['etrend']['0y'].earningsEstimateNumberOfAnalysts | number : 0]] [[financials['etrend']['+1y'].earningsEstimateNumberOfAnalysts | number : 0]]
Estimate Average [[financials['etrend']['0q'].earningsEstimateAvg | number : 2]] [[financials['etrend']['+1q'].earningsEstimateAvg | number : 2]] [[financials['etrend']['0y'].earningsEstimateAvg | number : 2]] [[financials['etrend']['+1y'].earningsEstimateAvg | number : 2]]
Estimate High [[financials['etrend']['0q'].earningsEstimateHigh | number : 2]] [[financials['etrend']['+1q'].earningsEstimateHigh | number : 2]] [[financials['etrend']['0y'].earningsEstimateHigh | number : 2]] [[financials['etrend']['+1y'].earningsEstimateHigh | number : 2]]
Estimate Low [[financials['etrend']['0q'].earningsEstimateLow | number : 2]] [[financials['etrend']['0q'].earningsEstimateLow | number : 2]] [[financials['etrend']['0y'].earningsEstimateLow | number : 2]] [[financials['etrend']['+1y'].earningsEstimateLow | number : 2]]
Estimate Growth [[financials['etrend']['0q'].earningsEstimateGrowth | number : 2]] [[financials['etrend']['+1q'].earningsEstimateGrowth | number : 2]] [[financials['etrend']['0y'].earningsEstimateGrowth | number : 2]] [[financials['etrend']['+1y'].earningsEstimateGrowth | number : 2]]
Year Ago EPS [[financials['etrend']['0q'].earningsEstimateYearAgoEps | number : 2]] [[financials['etrend']['+1q'].earningsEstimateYearAgoEps | number : 2]] [[financials['etrend']['0y'].earningsEstimateYearAgoEps | number : 2]] [[financials['etrend']['+1y'].earningsEstimateYearAgoEps | number : 2]]
All numbers in thousands (except analysts) Cur Qtr ([[financials['etrend']['0q'].date | strtotimestamp | date: 'MMM yyyy']]) Next Qtr ([[financials['etrend']['+1q'].date | strtotimestamp | date: 'MMM yyyy']]) Cur Year ([[financials['etrend']['0y'].date | strtotimestamp | date: 'MMM yyyy']]) Next Year ([[financials['etrend']['+1y'].date | strtotimestamp | date: 'MMM yyyy']])
Revenue Estimate
Number of Analysts [[financials['etrend']['0q'].revenueEstimateNumberOfAnalysts | number : 0]] [[financials['etrend']['+1q'].revenueEstimateNumberOfAnalysts | number : 0]] [[financials['etrend']['0y'].revenueEstimateNumberOfAnalysts | number : 0]] [[financials['etrend']['+1y'].revenueEstimateNumberOfAnalysts | number : 0]]
Estimate Average [[financials['etrend']['0q'].revenueEstimateAvg / 1000 | number : 0]] [[financials['etrend']['+1q'].revenueEstimateAvg / 1000 | number : 0]] [[financials['etrend']['0y'].revenueEstimateAvg / 1000 | number : 0]] [[financials['etrend']['+1y'].revenueEstimateAvg / 1000 | number : 0]]
Estimate High [[financials['etrend']['0q'].revenueEstimateHigh / 1000 | number : 0]] [[financials['etrend']['+1q'].revenueEstimateHigh / 1000 | number : 0]] [[financials['etrend']['0y'].revenueEstimateHigh / 1000 | number : 0]] [[financials['etrend']['+1y'].revenueEstimateHigh / 1000 | number : 0]]
Estimate Low [[financials['etrend']['0q'].revenueEstimateLow / 1000 | number : 0]] [[financials['etrend']['0q'].revenueEstimateLow / 1000 | number : 0]] [[financials['etrend']['0y'].revenueEstimateLow / 1000 | number : 0]] [[financials['etrend']['+1y'].revenueEstimateLow / 1000 | number : 0]]
Estimate Growth [[financials['etrend']['0q'].revenueEstimateGrowth * 100 | number : 2]]% [[financials['etrend']['+1q'].revenueEstimateGrowth * 100 | number : 2]]% [[financials['etrend']['0y'].revenueEstimateGrowth * 100 | number : 2]]% [[financials['etrend']['+1y'].revenueEstimateGrowth * 100| number : 2]]%
Year Ago EPS [[financials['etrend']['0q'].revenueEstimateYearAgoEps | number : 0]] [[financials['etrend']['+1q'].revenueEstimateYearAgoEps | number : 0]] [[financials['etrend']['0y'].revenueEstimateYearAgoEps | number : 0]] [[financials['etrend']['+1y'].revenueEstimateYearAgoEps | number : 0]]
Cur Qtr ([[financials['etrend']['0q'].date | strtotimestamp | date: 'MMM yyyy']]) Next Qtr ([[financials['etrend']['+1q'].date | strtotimestamp | date: 'MMM yyyy']]) Cur Year ([[financials['etrend']['0y'].date | strtotimestamp | date: 'MMM yyyy']]) Next Year ([[financials['etrend']['+1y'].date | strtotimestamp | date: 'MMM yyyy']])
EPS Trend
Current Estimate [[financials['etrend']['0q'].epsTrendCurrent | number : 2]] [[financials['etrend']['+1q'].epsTrendCurrent | number : 2]] [[financials['etrend']['0y'].epsTrendCurrent | number : 2]] [[financials['etrend']['+1y'].epsTrendCurrent | number : 2]]
7 Days Ago [[financials['etrend']['0q'].epsTrend7daysAgo | number : 2]] [[financials['etrend']['+1q'].epsTrend7daysAgo | number : 2]] [[financials['etrend']['0y'].epsTrend7daysAgo| number : 2]] [[financials['etrend']['+1y'].epsTrend7daysAgo | number : 2]]
30 Days Ago [[financials['etrend']['0q'].epsTrend30daysAgo | number : 2]] [[financials['etrend']['+1q'].epsTrend30daysAgo | number : 2]] [[financials['etrend']['0y'].epsTrend30daysAgo | number : 2]] [[financials['etrend']['+1y'].epsTrend30daysAgo | number : 2]]
60 Days Ago [[financials['etrend']['0q'].epsTrend60daysAgo | number : 2]] [[financials['etrend']['+1q'].epsTrend60daysAgo | number : 2]] [[financials['etrend']['0y'].epsTrend60daysAgo | number : 2]] [[financials['etrend']['+1y'].epsTrend60daysAgo | number : 2]]
90 Days Ago [[financials['etrend']['0q'].epsTrend90daysAgo | number : 2]] [[financials['etrend']['+1q'].epsTrend90daysAgo | number : 2]] [[financials['etrend']['0y'].epsTrend90daysAgo | number : 2]] [[financials['etrend']['+1y'].epsTrend90daysAgo | number : 2]]
Cur Qtr ([[financials['etrend']['0q'].date | strtotimestamp | date: 'MMM yyyy']]) Next Qtr ([[financials['etrend']['+1q'].date | strtotimestamp | date: 'MMM yyyy']]) Cur Year ([[financials['etrend']['0y'].date | strtotimestamp | date: 'MMM yyyy']]) Next Year ([[financials['etrend']['+1y'].date | strtotimestamp | date: 'MMM yyyy']])
EPS Revisions
Up Last 7 Days [[financials['etrend']['0q'].epsRevisionsUpLast7days | number : 0]] [[financials['etrend']['+1q'].epsRevisionsUpLast7days | number : 0]] [[financials['etrend']['0y'].epsRevisionsUpLast7days | number : 0]] [[financials['etrend']['+1y'].epsRevisionsUpLast7days | number : 0]]
Up Last 30 Days [[financials['etrend']['0q'].epsRevisionsUpLast30days | number : 0]] [[financials['etrend']['+1q'].epsRevisionsUpLast30days | number : 0]] [[financials['etrend']['0y'].epsRevisionsUpLast30days| number : 0]] [[financials['etrend']['+1y'].epsRevisionsUpLast30days | number : 0]]
Down Last 30 Days [[financials['etrend']['0q'].epsRevisionsDownLast7days | number : 0]] [[financials['etrend']['+1q'].epsRevisionsDownLast7days | number : 0]] [[financials['etrend']['0y'].epsRevisionsDownLast7days | number : 0]] [[financials['etrend']['+1y'].epsRevisionsDownLast7days | number : 0]]
Down Last 90 Days [[financials['etrend']['0q'].epsRevisionsDownLast30days | number : 0]] [[financials['etrend']['+1q'].epsRevisionsDownLast30days | number : 0]] [[financials['etrend']['0y'].epsRevisionsDownLast30days | number : 0]] [[financials['etrend']['+1y'].epsRevisionsDownLast30days | number : 0]]
 
Date Open High Low Close Volume
[[data.Date]] [[data.Open | number : 2]] [[data.High | number : 2]] [[data.Low | number : 2]] [[data.Close | number : 2]] [[data.Volume | number : 0]]